Difference between revisions of "He JT, et al. Mol. Cell. Proteom. (2012) cited as Ref 679 in DOI: 10.1038/s41392-020-0110-5 (Q9942)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Published In Name String (P102): Mol. Cell. Proteom., #quickstatements; #temporary_batch_1590006349955)
(‎Created claim: Page(s) (P105): M111.010744-, #quickstatements; #temporary_batch_1590074839150)
 
(2 intermediate revisions by the same user not shown)
Property / Volume
 +
11
Property / Volume: 11 / rank
 +
Normal rank
Property / title
 +
CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (English)
Property / title: CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (English) / rank
 +
Normal rank
Property / Page(s)
 +
M111.010744-
Property / Page(s): M111.010744- / rank
 +
Normal rank

Latest revision as of 15:49, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
He JT, et al. Mol. Cell. Proteom. (2012) cited as Ref 679 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    He JT
    0 references
    2012
    0 references
    Mol. Cell. Proteom.
    0 references
    11
    0 references
    CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays (English)
    0 references
    M111.010744-
    0 references